Sign in
4

Changes in Ownership

Harmony Biosciences Holdings, Inc. Filed Acc 0001615993-25-000005

PRESIDENT, CEO sold 25,933 shares at $40.11 ($1,040,103)

  • PRESIDENT, CEO acquired 20,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Dayno Jeffrey M. · PRESIDENT, CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-12-12 Exercise or conversion : show line 1 in the form 10b5-1 +20,000 $8.22 $164,400 20,000 D
2025-12-12 Sale : show line 2 in the form 10b5-1 −20,000 $40.11 $802,146 0 D
2025-12-12 Sale : show line 3 in the form 10b5-1 −5,933 $40.11 $237,957 0 D
Open-market sales · 25,933 sh · avg $40.11 · $1,040,103

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-12 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option −20,000 0 D
Loading xslF345X05/form4-12172025_051201.xml…